A real world study of Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) regimen in Hodgkin's lymphoma patients
Latest Information Update: 24 Jan 2019
At a glance
- Drugs Bendamustine (Primary) ; Gemcitabine (Primary) ; Vinorelbine (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
Most Recent Events
- 24 Jan 2019 New trial record
- 04 Dec 2018 Results assessing efficacy of Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) regimen in patients with Hodgkin's lymphoma, presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.